https://www.arnoldporter.com/en/perspectives/events/2021/04/banking-finance-update-consumer-protection https://www.arnoldporter.com/en/perspectives/events/2021/04/biden-admin-policy-in-indo-pacific-region https://www.arnoldporter.com/en/perspectives/events/2021/04/build-back-better-the-bidenharris-2-trillion https://www.arnoldporter.com/en/perspectives/events/2021/04/federal-regulatory-trends-in-consumer-health https://www.arnoldporter.com/en/perspectives/events/2021/04/understanding-the-biden-administrations-potential https://www.arnoldporter.com/en/perspectives/events/2021/05/banking-and-finance-update-intelligent-use-of-ai https://www.arnoldporter.com/en/perspectives/events/2021/05/hot-topics-in-arbitration--with-kcab-international https://www.arnoldporter.com/en/perspectives/events/2021/05/policymaker-speaker-series--us-reps-gottheimer https://www.arnoldporter.com/en/perspectives/events/2021/05/recent-developments-in-the-student-loan-sector https://www.arnoldporter.com/en/perspectives/events/2021/05/the-impact-of-the-bidenharris-administrations https://www.arnoldporter.com/en/perspectives/events/2021/05/under-washingtons-glare-understanding https://www.arnoldporter.com/en/perspectives/events/2021/06/integration-of-foci-mitigation-into-deal-structure https://www.arnoldporter.com/en/perspectives/events/2021/06/recent-fintech-developments-in-the-financial https://www.arnoldporter.com/en/perspectives/events/2021/06/the-attorneyclient-privilege-for-inhouse-counsel https://www.arnoldporter.com/en/perspectives/events/2021/06/when-cfius-comes-knocking-national-security https://www.arnoldporter.com/en/perspectives/events/2021/07/addressing-emerging-issues-in-online-selling https://www.arnoldporter.com/en/perspectives/events/2021/07/recent-financial-services-industry-updates https://www.arnoldporter.com/en/perspectives/events/2021/07/spac-roundtable-will-terms-change https://www.arnoldporter.com/en/perspectives/events/2021/09/the-biden-administration-reconciliation-bill https://www.arnoldporter.com/en/perspectives/events/2021/10/getting-the-mandate-straight-covid-19 https://www.arnoldporter.com/en/perspectives/events/2021/10/spacs-101 https://www.arnoldporter.com/en/perspectives/events/2021/10/whats-next-in-the-drive-to-netzero https://www.arnoldporter.com/en/perspectives/events/2021/10/your-files-have-been-encrypted https://www.arnoldporter.com/en/perspectives/events/2021/11/arbitrator-impartiality-independence-vs https://www.arnoldporter.com/en/perspectives/events/2021/11/navigating-todays-privacy-laws--around-the-world https://www.arnoldporter.com/en/perspectives/events/2021/11/spac-roundtable-state-of-the-spac-market https://www.arnoldporter.com/en/perspectives/events/2021/11/the-united-states-and-international-law-under https://www.arnoldporter.com/en/perspectives/events/2021/12/the-athens-roundtable https://www.arnoldporter.com/en/perspectives/events/2021/12/us-life-sciences-regulatory-and-enforcement-update https://www.arnoldporter.com/en/perspectives/events/2022/01/a-beginners-guide-to-life-sciences-ma-deals https://www.arnoldporter.com/en/perspectives/events/2022/01/antitrust-2021-in-review https://www.arnoldporter.com/en/perspectives/events/2022/01/consumer-health-and-personal-care-products https://www.arnoldporter.com/en/perspectives/events/2022/01/kick-off-the-new-year-with-qui-notes-false https://www.arnoldporter.com/en/perspectives/events/2022/01/regulatory-and-enforcement-trends-for-aml https://www.arnoldporter.com/en/perspectives/events/2022/01/shareholder-engagement-and-activism--in-the-ls https://www.arnoldporter.com/en/perspectives/events/2022/01/trademark-and-copyright-update-leading-2021-cases https://www.arnoldporter.com/en/perspectives/events/2022/02/data-protection-for-eu-and-uk--life-sciences-co https://www.arnoldporter.com/en/perspectives/events/2022/02/navigating-congressional-investigations https://www.arnoldporter.com/en/perspectives/events/2022/03/launching-digital-health-products-in-the-eu-and-uk https://www.arnoldporter.com/en/perspectives/events/2022/03/medical-product-supply-chains https://www.arnoldporter.com/en/perspectives/events/2022/03/pfas-regulatory-and-litigation-developments https://www.arnoldporter.com/en/perspectives/events/2022/03/russia-ukraine-a-strategic-and-legal-assessment https://www.arnoldporter.com/en/perspectives/events/2022/04/esg-issues-facing-issuers https://www.arnoldporter.com/en/perspectives/events/2022/04/marketing-funds-in-europe-navigating-and-solving https://www.arnoldporter.com/en/perspectives/events/2022/04/russiaukraine-a-strategic-and-legal-assessment https://www.arnoldporter.com/en/perspectives/events/2022/05/carbon-capture-sequestration-law https://www.arnoldporter.com/en/perspectives/events/2022/05/cartel-enforcement-in-the-us-and-eu-opportunities https://www.arnoldporter.com/en/perspectives/events/2022/05/competition-law-update-on-cases-and-topics https://www.arnoldporter.com/en/perspectives/events/2022/05/fda-civil-and-criminal-investigations https://www.arnoldporter.com/en/perspectives/events/2022/05/legislative-trends-impacting-consumer-health https://www.arnoldporter.com/en/perspectives/events/2022/05/session-three-esg-issues-facing-issuers https://www.arnoldporter.com/en/perspectives/events/2022/05/session-two-esg-issues-facing-issuers https://www.arnoldporter.com/en/perspectives/events/2022/06/chinas-geopolitical-agenda-the-us-response https://www.arnoldporter.com/en/perspectives/events/2022/06/key-developments-in-uk-and-us-employment-law https://www.arnoldporter.com/en/perspectives/events/2022/06/russiaukraine-crisis-nationalization https://www.arnoldporter.com/en/perspectives/events/2022/07/2022-euuk-life-sciences-bootcamp https://www.arnoldporter.com/en/perspectives/events/2022/07/west-virginia-v-epa https://www.arnoldporter.com/en/perspectives/events/2022/08/navigating-change-in-chile https://www.arnoldporter.com/en/perspectives/events/2022/09/and-so-it-flows-a-fireside-chat-with-castroedwards https://www.arnoldporter.com/en/perspectives/events/2022/09/fda-manufacturing-compliance-and-inspections https://www.arnoldporter.com/en/perspectives/events/2022/09/how-to-elevate-your-litigation-teams-and-win https://www.arnoldporter.com/en/perspectives/events/2022/09/uk-eu-annual-life-sciences-conference https://www.arnoldporter.com/en/perspectives/events/2022/11/managing-regulatory-risks-while-developing https://www.arnoldporter.com/en/perspectives/events/2022/11/navigating-the-post-election-landscape https://www.arnoldporter.com/en/perspectives/events/2022/11/securities-enforcement-forum-2022 https://www.arnoldporter.com/en/perspectives/events/2022/11/the-hidden-world-of-international-arbitration https://www.arnoldporter.com/en/perspectives/events/2022/12/all-eyes-on-influencers-how-life-sciences https://www.arnoldporter.com/en/perspectives/events/2022/12/strategies-for-managing-new-employee https://www.arnoldporter.com/en/perspectives/events/2023/01/kick-off-the-new-year-with-qui-notes-false-claims https://www.arnoldporter.com/en/perspectives/events/2023/01/three-part-webinar-series-antitrust-2022-year https://www.arnoldporter.com/en/perspectives/events/2023/01/what-your-company-needs-to-know-regarding https://www.arnoldporter.com/en/perspectives/events/2023/02/making-sense-of-the-changing-regulatory-landscape https://www.arnoldporter.com/en/perspectives/events/2023/02/regulatory-and-enforcement-trends-for-aml https://www.arnoldporter.com/en/perspectives/events/2023/03/account-balance-weighing-the-risks-associated https://www.arnoldporter.com/en/perspectives/events/2023/03/carbon-capture-and-sequestration https://www.arnoldporter.com/en/perspectives/events/2023/03/chips-act https://www.arnoldporter.com/en/perspectives/events/2023/03/spring-forward-trendy-ip-issues-2023-part-1 https://www.arnoldporter.com/en/perspectives/events/2023/04/esg-investigations-series-navigating-the-minefield https://www.arnoldporter.com/en/perspectives/events/2023/04/everything-you-want-to-know-about-a-career https://www.arnoldporter.com/en/perspectives/events/2023/04/rapid-response-pharma-strategy-proposal https://www.arnoldporter.com/en/perspectives/events/2023/04/schutteproctor-immediate-key-takeaways https://www.arnoldporter.com/en/perspectives/events/2023/04/spring-forward-trendy-ip-issues-in-2023-part-2 https://www.arnoldporter.com/en/perspectives/events/2023/05/ali-cle-conference https://www.arnoldporter.com/en/perspectives/events/2023/05/esg-investigations-series-learning-best-practices https://www.arnoldporter.com/en/perspectives/events/2023/05/spring-forward-trendy-ip-issues-in-2023-part-3 https://www.arnoldporter.com/en/perspectives/events/2023/06/arnold-porter-and-essex-court-chambers-panel https://www.arnoldporter.com/en/perspectives/events/2023/06/esg-investigations-series-internal-investigations https://www.arnoldporter.com/en/perspectives/events/2023/06/everexpanding-us-export-controls-and-the-foreign https://www.arnoldporter.com/en/perspectives/events/2023/07/a-busy-year-us-supreme-court-decides-two https://www.arnoldporter.com/en/perspectives/events/2023/07/decarbonization-of-the-aviation-sector-goals https://www.arnoldporter.com/en/perspectives/events/2023/07/epas-proposal-to-decarbonize-the-power-sector https://www.arnoldporter.com/en/perspectives/events/2023/07/twopart-webinar-series-federal-funding https://www.arnoldporter.com/en/perspectives/events/2023/08/the-proposed-revisions-to-the-ftc-doj https://www.arnoldporter.com/en/perspectives/events/2023/09/consumer-health-personal-care-products-litigation https://www.arnoldporter.com/en/perspectives/events/2023/09/eu-and-uk-life-sciences-conference https://www.arnoldporter.com/en/perspectives/events/2023/10/antitrust-developments-affecting-the-semiconductor-industry https://www.arnoldporter.com/en/perspectives/events/2023/10/emerging-issues-in-fda-inspections-and-oversight https://www.arnoldporter.com/en/perspectives/events/2023/10/pathway-to-medical-product-commercialization https://www.arnoldporter.com/en/perspectives/events/2023/10/securities-enforcement-forum https://www.arnoldporter.com/en/perspectives/events/2023/10/the-future-of-dei https://www.arnoldporter.com/en/perspectives/events/2023/11/latest-trends-with-ema-and-mhra-inspections https://www.arnoldporter.com/en/perspectives/events/2023/11/out-of-many-one-unifying-approaches https://www.arnoldporter.com/en/perspectives/events/2023/11/part-i-esg-an-overview-for-legal-professionals https://www.arnoldporter.com/en/perspectives/events/2023/11/project-2100-looking-back-looking-forward https://www.arnoldporter.com/en/perspectives/events/2023/12/looking-toward-2024-legislation-regulation https://www.arnoldporter.com/en/perspectives/events/2023/12/part-ii-key-developments-in-esg-related-regulation https://www.arnoldporter.com/en/perspectives/events/2023/12/the-2023-race-to-regulate-the-us-eu-and-uk https://www.arnoldporter.com/en/perspectives/events/2024/01/antitrust-2023-year-in-review-mergers-transactions https://www.arnoldporter.com/en/perspectives/events/2024/01/exploring-bank-capital-and-liquidity-alternative-solutions https://www.arnoldporter.com/en/perspectives/events/2024/01/new-years-resolutions-for-healthier https://www.arnoldporter.com/en/perspectives/events/2024/01/part-i-antitrust-mergers-transactions https://www.arnoldporter.com/en/perspectives/events/2024/01/part-ii-antitrust-litigation https://www.arnoldporter.com/en/perspectives/events/2024/01/what-the-pharmaceutical-biotech-and-device https://www.arnoldporter.com/en/perspectives/events/2024/02/consumer-health-what-to-know-about-recent-trends https://www.arnoldporter.com/en/perspectives/events/2024/02/distressed-asset-acquisition-opportunities-for-biopharma-companies https://www.arnoldporter.com/en/perspectives/events/2024/02/esg-part-iii-key-considerations-for-optimizing-governance https://www.arnoldporter.com/en/perspectives/events/2024/02/kick-off-the-new-year-with-qui-notes-false-claims https://www.arnoldporter.com/en/perspectives/events/2024/02/life-sciences-hot-topics-data-protection-and-competition https://www.arnoldporter.com/en/perspectives/events/2024/02/regulatory-and-enforcement-trends-for-aml-and-sanctions-in-2024 https://www.arnoldporter.com/en/perspectives/events/2024/02/willful-patent-infringement-enhanced-damages-and-opinions-of-counsel https://www.arnoldporter.com/en/perspectives/events/2024/03/legislative-briefing-for-counsel-and-advocates https://www.arnoldporter.com/en/perspectives/events/2024/04/ai-in-retail-and-consumer-products-managing-the-risks https://www.arnoldporter.com/en/perspectives/events/2024/04/aima-fund-manager-briefing-esg-and-the-sec https://www.arnoldporter.com/en/perspectives/events/2024/04/esg-series-part-iv-former-sec-enforcement-alumni-speak-on-esg-rules https://www.arnoldporter.com/en/perspectives/events/2024/04/fdas-final-ldt-rule-and-salient-issues-for-industry https://www.arnoldporter.com/en/perspectives/events/2024/04/free-discounted-and-valueadded-items-and-services https://www.arnoldporter.com/en/perspectives/events/2024/04/quality-management-inspections-and-the-evolving https://www.arnoldporter.com/en/perspectives/events/2024/05/ali-cle-accountants-liability-2024 https://www.arnoldporter.com/en/perspectives/events/2024/05/fda-regulatory-and-compliance-risks https://www.arnoldporter.com/en/perspectives/events/2024/05/hipaa-refresh-what-medical-device-and-pharma-companies-need-to-know https://www.arnoldporter.com/en/perspectives/events/2024/05/panel-discussion-on-credit-risk-transfer-crt-structures https://www.arnoldporter.com/en/perspectives/events/2024/05/part-v-navigating-the-web-of-climate-and-sustainability https://www.arnoldporter.com/en/perspectives/events/2024/05/the-rescheduling-of-cannabis-what-it-means-next-step https://www.arnoldporter.com/en/perspectives/events/2024/05/what-goliaths-should-know-about-davids-small-business https://www.arnoldporter.com/en/perspectives/events/2024/06/appraisal-bias-in-residential-mortgage-lending-key-insights-for-lenders https://www.arnoldporter.com/en/perspectives/events/2024/06/a-sneak-peek-into-plaintiffs-playbook-medical-device-product-liability-trends https://www.arnoldporter.com/en/perspectives/events/2024/06/eu-uk-life-sciences-medicines-bootcamp-20-june-2024 https://www.arnoldporter.com/en/perspectives/events/2024/06/former-sec-officials-on-life-sciences-companies-sec-enforcement https://www.arnoldporter.com/en/perspectives/events/2024/06/measure-twice-cut-once-commercial https://www.arnoldporter.com/en/perspectives/events/2024/06/navigating-issues-in-distressed-securitized-and-non-securitized https://www.arnoldporter.com/en/perspectives/events/2024/06/the-end-of-chevron-scotus-rules-on-loper-bright https://www.arnoldporter.com/en/perspectives/events/2024/06/trademarks-and-copyrights-where-weve-been-and-what-were-watching-in-2024 https://www.arnoldporter.com/en/perspectives/events/2024/07/2024-midyear-update-developments-in-us-antitrust-enforcement-litigation https://www.arnoldporter.com/en/perspectives/events/2024/07/firing-on-all-cylinders-a-look-at-the-cfpbs-agenda-in-the-aftermath-of-cfpb-v-cfsa https://www.arnoldporter.com/en/perspectives/events/2024/07/raps-dc-baltimore-chapter-in-person-event-fda-panel-event https://www.arnoldporter.com/en/perspectives/events/2024/07/sec-vs-jarkesy-implications-of-a-groundbreaking-decision https://www.arnoldporter.com/en/perspectives/events/2024/08/how-the-2023-2024-supreme-court-term-will-affect-the-financial-services-industry https://www.arnoldporter.com/en/perspectives/events/2024/08/how-the-2023-2024-supreme-court-term-will-affect-the-financial-services-industry-pt2 https://www.arnoldporter.com/en/perspectives/events/2024/09/energy-transition-law-and-policy-current-status-and-election-outlook https://www.arnoldporter.com/en/perspectives/events/2024/09/how-the-2023-2024-supreme-court-term-will-affect-the-financial-services-industry-pt3 https://www.arnoldporter.com/en/perspectives/events/2024/09/nuts-and-bolts-of-a-government-investigation https://www.arnoldporter.com/en/perspectives/events/2024/09/regulatory-and-compliance-hot-topics-for-west-coast-life-sciences https://www.arnoldporter.com/en/perspectives/events/2024/09/scotus-rules-implications-of-a-groundbreaking-decision https://www.arnoldporter.com/en/perspectives/events/2024/09/the-supreme-courts-2023-24-term-and-the-banking https://www.arnoldporter.com/en/perspectives/events/2024/09/uk-eu-life-sciences-conference https://www.arnoldporter.com/en/perspectives/events/2024/09/unexpected-encounters-what-to-do-when-the-government-shows-up https://www.arnoldporter.com/en/perspectives/events/2024/10/auwcl-center-on-international-commercial-arbitration https://www.arnoldporter.com/en/perspectives/events/2024/10/bootcamp-on-the-development-and-commercialization-of-medicinal-products-in-europe https://www.arnoldporter.com/en/perspectives/events/2024/10/consumer-arbitration-agreements-benefits-best-practices-and-common-pitfalls https://www.arnoldporter.com/en/perspectives/events/2024/10/end-of-the-qui-tam https://www.arnoldporter.com/en/perspectives/events/2024/10/know-your-regulator-how-to-effectively-engage-fda https://www.arnoldporter.com/en/perspectives/events/2024/10/nuts-and-bolts-of-a-government-investigation https://www.arnoldporter.com/en/perspectives/events/2024/11/arnold-porters-2024-benchmark-survey-report-on-the-convergence-of-life-sciences-and-ai https://www.arnoldporter.com/en/perspectives/events/2024/11/life-sciences-company-inlicensing-from-universities-and-other-taxexempt-entities https://www.arnoldporter.com/en/perspectives/events/2024/11/navigating-the-postelection-landscape-with-arnold-porter https://www.arnoldporter.com/en/perspectives/events/2024/11/nuts-and-bolts-of-a-government-investigation-part-3 https://www.arnoldporter.com/en/perspectives/events/2024/12/regulatory-changes-in-food-and-other-fda-regulated-consumer-products https://www.arnoldporter.com/en/perspectives/events/2025/01/18th-forum-on-the-foreign-corrupt-practices-act-houston https://www.arnoldporter.com/en/perspectives/events/2025/01/energy-and-the-energy-transition-in-the-trump-administration-key-early-developments https://www.arnoldporter.com/en/perspectives/events/2025/01/join-arnold-porters-global-life-sciences-industry-group-in-san-francisco https://www.arnoldporter.com/en/perspectives/events/2025/01/navigating-consumer-protection-what-the-new-trump-administration-means-for-consumer-product https://www.arnoldporter.com/en/perspectives/events/2025/01/navigating-early-stage-ma-in-biotech-challenges-and-opportunities https://www.arnoldporter.com/en/perspectives/events/2025/01/regulatory-and-enforcement-trends-for-aml-and-sanctions-in-2025 https://www.arnoldporter.com/en/perspectives/events/2025/01/what-the-pharmaceutical-biotech-and-device-industries-should-expect-in-2025 https://www.arnoldporter.com/en/perspectives/events/2025/02/exploring-the-future-of-dei-the-impact-of-president-trumps-executive-orders https://www.arnoldporter.com/en/perspectives/events/2025/02/kick-off-the-new-year-with-qui-notes-false-claims-act-fy24-year-in-review-and-an-early-look-at-fy25 https://www.arnoldporter.com/en/perspectives/events/2025/02/nuts-and-bolts-of-a-government-investigation-part-4 https://www.arnoldporter.com/en/perspectives/events/2025/02/raising-red-flags-addressing-claims-of-corruption-in-arbitration https://www.arnoldporter.com/en/perspectives/events/2025/02/seeing-around-the-corner-what-enforcement-actions-to-expect-under-the-new-administration https://www.arnoldporter.com/en/perspectives/events/2025/02/the-first-in-a-critical-medical-device-issues-series https://www.arnoldporter.com/en/perspectives/events/2025/03/antitrust-2025-forecasting-the-future-of-competition-enforcement-part-1 https://www.arnoldporter.com/en/perspectives/events/2025/03/critical-medical-device-series-part-ii-navigating-the-tightrope-balancing-data-use https://www.arnoldporter.com/en/perspectives/events/2025/03/energys-new-frontier-navigating-disputes-and-mitigating-contract-risks-for-increased-fossil-fuel https://www.arnoldporter.com/en/perspectives/events/2025/03/global-esg-considerations-in-a-second-trump-administration https://www.arnoldporter.com/en/perspectives/events/2025/03/hot-topics-in-ip-and-artificial-intelligence-and-important-antitrust-considerations https://www.arnoldporter.com/en/perspectives/events/2025/03/navigating-new-frontiers-us-and-eu-semiconductor-policy-shifts-under-new-administrations https://www.arnoldporter.com/en/perspectives/events/2025/03/postelection-landscape-for-the-banking-industry https://www.arnoldporter.com/en/perspectives/events/2025/03/sec-transitions-to-edgar-next-filing-system https://www.arnoldporter.com/en/perspectives/events/2025/04/antitrust-2025-forecasting-the-future-of-competition-enforcement-part-2 https://www.arnoldporter.com/en/perspectives/events/2025/04/antitrust-2025-forecasting-the-future-of-competition-enforcement-part-3 https://www.arnoldporter.com/en/perspectives/events/2025/04/critical-medical-device-series-part-iii-conducting-effective-due-diligence-in-medtech-transactions https://www.arnoldporter.com/en/perspectives/events/2025/04/financing-the-future-an-evening-of-cocktails-conversation-with-the-west-african-development-bank https://www.arnoldporter.com/en/perspectives/events/2025/04/food-and-color-additives-and-the-maha-agenda https://www.arnoldporter.com/en/perspectives/events/2025/04/navigating-fda-compliance-and-civil-litigation-strategies-for-food-and-medical-product-companies https://www.arnoldporter.com/en/perspectives/events/2025/05/critical-medical-device-series-part-iv-ip-considerations-for-diagnostics-and-biomarkers-section-101 https://www.arnoldporter.com/en/perspectives/events/2025/05/energy-and-environmental-policy-beyond-the-first-100-days-legal-perspectives https://www.arnoldporter.com/en/perspectives/events/2025/05/litigating-against-federal-government-agencies-a-primer-for-life-sciences-companies https://www.arnoldporter.com/en/perspectives/events/2025/05/navigating-emerging-epr-requirements-in-a-dynamic-global-regulatory-environment https://www.arnoldporter.com/en/perspectives/events/2025/05/nuts-and-bolts-of-a-government-investigation-part-5 https://www.arnoldporter.com/en/perspectives/events/2025/06/ali-cle-accountants-liability-2025 https://www.arnoldporter.com/en/perspectives/events/2025/06/critical-medical-device-series-part-v-mitigating-litigation-risks-for-ai-enabled-or-assisted https://www.arnoldporter.com/en/perspectives/events/2025/06/emerging-risks-with-microplastics-what-consumer-product-companies-need-to-know https://www.arnoldporter.com/en/perspectives/events/2025/06/euuk-life-sciences-medicines-bootcamp https://www.arnoldporter.com/en/perspectives/events/2025/06/navigating-antitrust-compliance-best-practices-for-pricing-contracting-and-distribution https://www.arnoldporter.com/en/perspectives/events/2025/06/navigating-the-enforcement-and-regulatory-landscape-of-recurring-subscription-practices https://www.arnoldporter.com/en/perspectives/events/2025/07/ai-llowed-or-infringing-are-ai-research-tools-protected-under-the-safe-harbor https://www.arnoldporter.com/en/perspectives/events/2025/07/a-life-sciences-case-study-on-the-new-eu-product-liability-directive https://www.arnoldporter.com/en/perspectives/events/2025/07/banking-digital-assets-key-aml-compliance-considerations https://www.arnoldporter.com/en/perspectives/events/2025/07/critical-medical-device-series-part-vi-navigating-innovation-the-fdas-role-in-regulating-medical https://www.arnoldporter.com/en/perspectives/events/2025/08/critical-medical-device-series-part-vii-fdas-and-ftcs-roles-in-medtech-promotion-and-advertising https://www.arnoldporter.com/en/perspectives/events/2025/08/stablecoin-legislation-is-here-is-your-institution-ready https://www.arnoldporter.com/en/perspectives/events/2025/09/critical-medical-device-series-part-viii-regulatory-strategies-in-europe-for-medtech https://www.arnoldporter.com/en/perspectives/events/2025/09/uk-and-eu-annual-life-sciences-conference-plus-us-life-sciences-developments-for-european-counsel https://www.arnoldporter.com/en/perspectives/events/2025/10/a-new-doj-approach-to-trade-enforcement-old-tools-used-for-new-policies https://www.arnoldporter.com/en/perspectives/events/2025/10/beyond-the-great-wall-entering-and-succeeding-in-chinas-medtech-market https://www.arnoldporter.com/en/perspectives/events/2025/10/charter-alternatives-for-non-banks-opportunities-and-challenges-for-digital-asset-firms https://www.arnoldporter.com/en/perspectives/events/2025/10/impact-of-tariffs-global-regulation-on-business https://www.arnoldporter.com/en/perspectives/events/2025/10/key-issues-in-uk-and-us-employment-law-what-you-need-to-know https://www.arnoldporter.com/en/perspectives/events/2025/10/next-frontiers-in-product-liability-litigation-trends-and-tactics-in-the-changing-courtroom https://www.arnoldporter.com/en/perspectives/events/2025/10/the-26th-annual-pharmaceutical-and-medical-device-ethics-and-compliance-congress https://www.arnoldporter.com/en/perspectives/events/2025/11/auwcl-center-on-international-commercial-arbitration https://www.arnoldporter.com/en/perspectives/events/2025/11/competition-bootcamp-for-inhouse-life-sciences-lawyers https://www.arnoldporter.com/en/perspectives/events/2025/11/complete-response-letters-in-transition-navigating-fdas-transparency-policy-and-manufacturingrelated https://www.arnoldporter.com/en/perspectives/events/2025/11/critical-medical-device-series-part-x-balancing-risk-and-innovation-fraud-and-abuse-trends https://www.arnoldporter.com/en/perspectives/events/2025/12/close-the-year-out-with-qui-notes-false-claims-act-fy25-year-in-review https://www.arnoldporter.com/en/perspectives/events/2025/12/executive-briefing-risks-to-latin-american-banks-from-recent-us-sanctions-actions https://www.arnoldporter.com/en/perspectives/events/2025/12/the-defendant-strikes-back-using-a-motion-to-strike-to-narrow-putative-class-claims https://www.arnoldporter.com/en/perspectives/events/2026/01/2025-year-in-review-litigation-and-regulatory-developments-impacting https://www.arnoldporter.com/en/perspectives/events/2026/01/jp-morgan-healthcare-conference https://www.arnoldporter.com/en/perspectives/events/2026/01/navigating-the-biosecure-act https://www.arnoldporter.com/en/perspectives/events/2026/01/trump-venezuela-and-the-future-of-us-engagement-in-the-americas-implications-for-business https://www.arnoldporter.com/en/perspectives/events/2026/01/venture-philanthropy-strategic-impact-vc-and-blended-finance-strategies https://www.arnoldporter.com/en/perspectives/events/2026/02/aml-sanctions-in-2026-trends-risks-and-how-to-stay-ahead https://www.arnoldporter.com/en/perspectives/events/2026/02/antitrust-2026-and-beyond-a-global-outlook-on-competition-enforcement-part-1 https://www.arnoldporter.com/en/perspectives/events/2026/02/antitrust-2026-and-beyond-a-global-outlook-on-competition-enforcement-part-2 https://www.arnoldporter.com/en/perspectives/events/2026/02/antitrust-2026-and-beyond-a-global-outlook-on-competition-enforcement-part-3 https://www.arnoldporter.com/en/perspectives/events/2026/02/extended-producer-responsibility-lessons-learned-and-whats-ahead https://www.arnoldporter.com/en/perspectives/events/2026/03/advancing-ai-adoption-in-manufacturing-under-the-existing-fda-ema-frameworks https://www.arnoldporter.com/en/perspectives/events/2026/03/antitrust-2026-and-beyond-a-global-outlook-on-competition-enforcement-part-4 https://www.arnoldporter.com/en/perspectives/events/2026/03/arnold-porters-2026-life-sciences-future-forum https://www.arnoldporter.com/en/perspectives/events/2026/03/government-enforcement-trends https://www.arnoldporter.com/en/perspectives/events/2026/03/hot-topics-in-advertising-law-the-nad-and-drug-and-medical-device-promotion https://www.arnoldporter.com/en/perspectives/events/2026/03/life-sciences-transactions-bootcamp https://www.arnoldporter.com/en/perspectives/events/2026/03/policy-briefing-status-of-federal-permitting-reform-and-implications-for-infrastructure-energy https://www.arnoldporter.com/en/perspectives/events/2026/03/scotus-tariff-decision-refunds-impacts-and-strategic-considerations https://www.arnoldporter.com/en/perspectives/events/2026/03/the-american-bar-associations-criminal-justice-section-white-collar-crime-institute https://www.arnoldporter.com/en/perspectives/events/2026/03/the-future-of-banking-an-inperson-financial-services-summit https://www.arnoldporter.com/en/perspectives/events/2026/03/your-website-is-under-scrutiny-navigating-legal-and-regulatory-compliance-risks https://www.arnoldporter.com/en/perspectives/events/2026/04/a-guide-to-plaintiffs-litigation-playbook https://www.arnoldporter.com/en/perspectives/events/2026/04/ai-in-finance-summit-ny https://www.arnoldporter.com/en/perspectives/events/2026/04/an-insiders-guide-to-life-sciences-enforcement-one-year-into-the-new-administration https://www.arnoldporter.com/en/perspectives/events/2026/04/competition-bootcamp-webinar-for-inhouse-life-sciences-lawyers https://www.arnoldporter.com/en/perspectives/events/2026/04/deal-to-dispute-managing-risk-in-ma-and-commercial-transactions https://www.arnoldporter.com/en/perspectives/events/2026/04/transferring-data-safely-national-security-privacy-and-emerging-sovereign-rights https://www.arnoldporter.com/en/perspectives/events/2026/04/what-us-startups-need-to-know-about-the-uk-eu-gdpr https://www.arnoldporter.com/en/perspectives/events/2026/05/10-months-later-updates-on-us-stablecoin-law https://www.arnoldporter.com/en/perspectives/events/2026/06/eu-uk-medical-device-ivd-bootcamp